Remembering a Giant: R. Palmer Beasley

Details

Last Updated on Friday, 07 September 2012 15:00

Dr. R. Palmer Beasley's passing is a tremendous loss for the hepatitis community. He was a member of CEVHAP and Palmer and I were friends for nearly 40 years. I knew him very well, because he worked in Taiwan in 1970-80's and we both had a common interest in hepatitis research. He contributed a lot to our understanding of the epidemiology of hepatitis B, the etiologic role of hepatitis B virus (HBV) in hepatocellular carcinoma (HCC), and the immunoprophylaxis of HBV infection. His landmark discovery of "vertical" transmission of HBV from carrier mothers to their infants in early 1970's paved the road of hepatitis B vaccination. Indeed, he and colleagues went on to show the efficacy of hepatitis B immune globulin and hepatitis B vaccine in this setting, which laid the foundation of hepatitis B immunization in newborns. It is now a regular practice worldwide and this will avert millions of deaths due to end-stage liver disease and HCC.

Although the control of hepatitis B is on the right track, there are still many hurdles in its implementation. While CEVHAP is working toward the eradication of viral hepatitis in our region, we will all remember the giant who has contributed so much to what we are doing now.

D S Chen
Chair

An article in The New York Times:
R. Palmer Beasley, Expert on Hepatitis B, Dies at 76

Australian Specialist Develops New Tools for the Fight Against Hepatitis B

Details

Last Updated on Friday, 03 August 2012 01:57

Liverpool Hospital, Sydney NSW, at the launch of a set of innovative educational resources designed to improve the treatment rates of Australia’s approximately 170,000 hepatitis B sufferers and reduce the incidence of hepatitis B-related liver cancer and liver failure:

L to R:
Professor Stephen Locarnini, Director, World Health Organisation (WHO) Regional Reference Laboratory for Hepatitis B at the Victorian Infectious Diseases Reference Laboratory; Dr Kerry Chant, Chief Health Officer, NSW; Dr Miriam Levy, Head of Gastroenterology and Hepatology at Liverpool Hospital in Sydney

For more details:
CEVHAP - NSW Health Joint Press Release, 23 July 2012

CEVHAP Policy Symposium at APASL

Details

Last Updated on Wednesday, 25 July 2012 05:35

At the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL) held in Taipei, on 19 February 2012, CEVHAP staged its first symposium entitled: “Better health through better public policies – What we can learn from the HIV experience.”
[Programme]

Keynote speaker, Dr David Thomas, of Johns Hopkins School of Medicine in the USA, presented some compelling data emphasising the comparatively large number of deaths occurring as a result of viral hepatitis infection as opposed to the small amount of funding received by the sector - from both public and private sources . The Symposium highlighted the need to build far better public awareness about viral hepatitis and also the need for adequate surveillance data, lacking in many countries, upon which to build and develop sound policy responses.

Some key media articles following the symposium:

Express Pharma (India) Online, 16-31 March 2012
CEVHAP hosts agenda-setting meet on hepatitis policy

South China Morning Post, 13 March 2012
Going viral; Break the silence; Lessons from an earlier battle

South China Morning Post, 21 February 2012
A silent killer remains at large

World Hepatitis Day

Details

Last Updated on Wednesday, 18 July 2012 08:43

Many CEVHAP members across Asia Pacific have participated in a range of activities torecognise World Hepatitis Day in order to raise awareness and understanding in the community of the disease and its serious impact:

World Hepatitis Day Report from Lucknow, India 
World Hepatitis Day Coverage in Hong Kong 
World Hepatitis Day Coverage in Malaysia 
World Hepatitis Day Coverage in Taiwan 
World Hepatitis Day Coverage in Korea 
World Hepatitis Day Coverage in Indonesia 
World Hepatitis Day Coverage in China 
World Hepatitis Day Coverage in Thailand